This has been out since may and is not a guidelines for ova1. If anything its a disclaimer about using ova1 alone. The reference to the committee's opinion has not one word about ova1. If guidelines come, they will come from ACOG.
This is not guidelines, but as strong of a statement as you can get from sgo. THIS IS NOT OLD NEWS - came out late yesterday. This is a big deal. Of course shorts will say its not. Acog and sgo have worked together on this topic in the past, this sets the stage for acog changes, also makes it very difficult for payers not to cover the test.
The whole game is changing for vrml and we are in inning one.
SGO has in the past rolled out guidelines with acog. This is a very strong statement from an agency that doesn't endorse any products. Pressure being put on insurers - all this will lead to a higher stock price.